Business

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced that it will report its financial results

articleDyadic International, Inc.October 29, 20253/company/dyadic-international-inc/news/dyadic-report-third-quarter-2025-112500551
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

About this update from Dyadic International, Inc.

[{"type":"image","alt":"Dyadic International, Inc.","displaySize":"","headline":null,"caption":"Dyadic International, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":180,"url":"https://media.zenfs.com/en/globenewswire.com/2a288e59b65031a67c22f5fb4925ffb4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PBlJ.1nJfXGJZqZFhMHG6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI1MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2a288e59b65031a67c22f5fb4925ffb4","width":300,"height":180}},"lazy":false},{"type":"text","content":"JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications utilizing its proprietary gene expression platforms, today announced that it will report its financial results for the second quarter 2025 and host a corporate update conference call on Wednesday, November 12, 2025.","length":605,"tagName":"p"},{"type":"text","content":"Conference Call Information","length":27,"tagName":"p"},{"type":"text","content":"Date: Wednesday, November 12, 2025","length":34,"tagName":"p"},{"type":"text","content":"Time: 5:00 p.m. Eastern Time","length":28,"tagName":"p"},{"type":"text","content":"Dial-in numbers: Toll Free: +1-877-407-0784; International +1-201-689-8560","length":74,"tagName":"p"},{"type":"text","content":"Conference ID: 13751389","length":23,"tagName":"p"},{"type":"text","content":"Webcast Link:. https://viavid.webcasts.com/starthere.jsp?ei=1706029&tp_key=b177e95e36. An archive of the webcast will be available within 24 hours after completion of the live event and will be accessible on the Investor Relations section of the Company's website at www.dyadic.com. To access the replay of the webcast, please follow the webcast link above.","length":365,"tagName":"p"},{"type":"text","content":"If you have any questions that you would like to ask management during the Q&A session, please email [email protected] prior to the conference call.","length":155,"tagName":"p"},{"type":"text","content":"About Dyadic Applied BioSolutions","length":33,"tagName":"p"},{"type":"t...

More updates from Dyadic International, Inc.

Dyadic InternationalDyadic Applied BioSolutionsDyadic International, Inc.proprietary gene expression